Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials
- PMID: 2902922
Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials
Abstract
Tianeptine is a new antidepressant effective against anxiety accompanying mood disturbances. Its clinical properties have been assessed by double-blind controlled studies (versus imipramine, amitriptyline, nomifensine, viloxazine) in depressed patients fulfilling the diagnostic criteria of the DSM III: single recurrent major depressive episodes without melancholia or psychotic features, and dysthymic disorders. The authors have concluded that tianeptine is effective in depressive disorders as shown both by depression rating scales and subjective impressions of treated patients. This improvement increases regularly with time. Seventy-eight percent of patients were considered to be "responders" at the end of the treatment with tianeptine. Antidepressant activity of tianeptine is equally present in depressive states appearing after withdrawal from alcohol. In depressed patients with anxiety, the results also reveal the efficacy of tianeptine on anxiety symptoms. Tianeptine, in addition, shows a marked action on somatic complaints. These results have been confirmed by open long-term trials, particularly in the elderly. Tianeptine can be placed in a middle position in the bipolar classification, between the sedative and stimulant antidepressants. Its antidepressant and anxiolytic properties and its action on somatic complaints make the drug particularly suitable for the treatment of the entire range of depressive symptomatology.
Similar articles
-
Efficacy of tianeptine in comparative trials versus reference antidepressants. An overview.Br J Psychiatry Suppl. 1992 Feb;(15):72-5. Br J Psychiatry Suppl. 1992. PMID: 1389026
-
Position of tianeptine among antidepressive chemotherapies.Clin Neuropharmacol. 1988;11 Suppl 2:S97-102. Clin Neuropharmacol. 1988. PMID: 3052827 Review.
-
[Tolerability of tianeptine in 170 patients with depression treated during one year].Encephale. 1990 Nov-Dec;16(6):445-52. Encephale. 1990. PMID: 2101783 Clinical Trial. French.
-
Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression.Drugs. 1995 Mar;49(3):411-39. doi: 10.2165/00003495-199549030-00007. Drugs. 1995. PMID: 7774514 Review.
-
Tianeptine and amitriptyline. Controlled double-blind trial in depressed alcoholic patients.Neuropsychobiology. 1988;19(2):79-85. doi: 10.1159/000118439. Neuropsychobiology. 1988. PMID: 3067116 Clinical Trial.
Cited by
-
When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use.Am J Drug Alcohol Abuse. 2021 Jul 4;47(4):455-466. doi: 10.1080/00952990.2021.1904408. Epub 2021 Apr 28. Am J Drug Alcohol Abuse. 2021. PMID: 33909525 Free PMC article.
-
Moxie begets MOXI: The journey to a novel hypothesis about Mu-opioid and OXytocin system Interactions.Compr Psychoneuroendocrinol. 2024 Jun 26;19:100244. doi: 10.1016/j.cpnec.2024.100244. eCollection 2024 Aug. Compr Psychoneuroendocrinol. 2024. PMID: 39104824 Free PMC article. Review.
-
Effects of tianeptine on the performance of a reaching movement in the cat.Psychopharmacology (Berl). 1991;104(3):328-36. doi: 10.1007/BF02246032. Psychopharmacology (Berl). 1991. PMID: 1924641
-
Effects of tianeptine on symptoms of fibromyalgia via BDNF signaling in a fibromyalgia animal model.Korean J Physiol Pharmacol. 2017 Jul;21(4):361-370. doi: 10.4196/kjpp.2017.21.4.361. Epub 2017 Jun 26. Korean J Physiol Pharmacol. 2017. PMID: 28706449 Free PMC article.
-
Kinetic profiles of tianeptine and its MC5 metabolite in plasma, blood and brain after single and chronic intraperitoneal administration in the rat.Eur J Drug Metab Pharmacokinet. 1990 Jan-Mar;15(1):69-74. doi: 10.1007/BF03190130. Eur J Drug Metab Pharmacokinet. 1990. PMID: 2384119
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources